Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- CheckyesterdayChange DetectedNew history entries were added for Study Status (IDs 987–991). The entries cover dates from 2026-03-07 to 2026-03-13.SummaryDifference0.1%

- Check8 days agoChange DetectedNew revision entries were added to the history (including v3.4.3), and the older v3.4.2 entry was removed.SummaryDifference0.1%

- Check15 days agoChange DetectedNew history entries were added for the record, showing recent Study Status updates (versions 977–981) with their submission dates. This reflects record-keeping activity rather than changes to core study content.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded new history entries 973–976 with Study Status updates on 2026-02-14 to 2026-02-20, and removed the 2026-02-13 entry.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.4.2 was added, including new history entries for Study Status (IDs 970–972). The previous revision, v3.4.1, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedNew history entries from 2026-02-03 to 2026-02-06 show updated 'Study Status', and a new Revision: v3.4.1 was added while Revision: v3.4.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.